📊 SINT Key Takeaways
Is Sintx Technologies, Inc. (SINT) a Good Investment?
Sintx Technologies is in acute financial distress with a 64.7% YoY revenue collapse to $380K while burning $2.5M annually in operating cash flow. With only $1.9M in cash, $904K in equity, and deeply negative profitability across all metrics, the company has less than one year of cash runway at current burn rates. While the 37.9% gross margin suggests potential business model viability, the combination of severe revenue contraction, unsustainable cash burn, and minimal financial cushion presents imminent solvency risk.
Sintx Technologies, Inc. Key Strengths (SINT)
- Gross margin of 37.9% indicates product economics could support a profitable business at scale
- Minimal debt burden (Debt/Equity 0.01x) preserves financial flexibility
- Year-over-year loss improvements (39.3% on net income, 59.4% on EPS) show some operational progress
SINT Stock Risks: Sintx Technologies, Inc. Investment Risks
- Catastrophic 64.7% YoY revenue decline indicates severe product-market fit or commercialization failure in competitive medical device sector
- Operating cash burn of $2.5M annually against $1.9M cash balance creates imminent liquidity crisis with <12 month runway
- Stockholders' equity of only $904K leaves virtually no margin for error; company is technically insolvent in book value terms given liabilities of $6.9M
- Quick ratio of 0.70x indicates insufficient liquid assets; current ratio barely above 1.0x signals working capital stress
- Massive negative profitability metrics (Operating Margin -843.9%, Net Margin -742.4%) demonstrate business cannot sustain operations independently
Key Metrics to Watch
- Monthly recurring revenue trend and customer acquisition (assess if revenue decline is stabilizing)
- Cash balance and monthly burn rate (determine if near critical funding event)
- Gross profit dollars and customer concentration (identify if remaining revenue is sustainable or contingent)
Sintx Technologies, Inc. (SINT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Sintx Technologies, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
SINT Profit Margin, ROE & Profitability Analysis
SINT vs Healthcare Sector: How Sintx Technologies, Inc. Compares
How Sintx Technologies, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Sintx Technologies, Inc. Stock Overvalued? SINT Valuation Analysis 2026
Based on fundamental analysis, Sintx Technologies, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Sintx Technologies, Inc. Balance Sheet: SINT Debt, Cash & Liquidity
SINT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Sintx Technologies, Inc.'s revenue has grown significantly by 376% over the 5-year period, indicating strong business expansion. The most recent EPS of $-15.19 indicates the company is currently unprofitable.
SINT Revenue Growth, EPS Growth & YoY Performance
SINT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $369.0K | -$2.3M | $-0.70 |
| Q3 2025 | $208.0K | -$886.0K | $-3.46 |
| Q2 2025 | $151.0K | -$886.0K | $-0.91 |
| Q1 2025 | $369.0K | -$886.0K | $-1.29 |
| Q3 2024 | $678.0K | -$293.0K | $-6.96 |
| Q2 2024 | $508.0K | -$293.0K | $-3.61 |
| Q1 2024 | $539.0K | -$293.0K | $-0.11 |
| Q3 2023 | $426.0K | -$293.0K | $-0.81 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Sintx Technologies, Inc. Dividends, Buybacks & Capital Allocation
SINT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Sintx Technologies, Inc. (CIK: 0001269026)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SINT
What is the AI rating for SINT?
Sintx Technologies, Inc. (SINT) has an AI grade of D with 96% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SINT's key strengths?
Claude: Gross margin of 37.9% indicates product economics could support a profitable business at scale. Minimal debt burden (Debt/Equity 0.01x) preserves financial flexibility.
What are the risks of investing in SINT?
Claude: Catastrophic 64.7% YoY revenue decline indicates severe product-market fit or commercialization failure in competitive medical device sector. Operating cash burn of $2.5M annually against $1.9M cash balance creates imminent liquidity crisis with <12 month runway.
What is SINT's revenue and growth?
Sintx Technologies, Inc. reported revenue of $380.0K.
Does SINT pay dividends?
Sintx Technologies, Inc. does not currently pay dividends.
Where can I find SINT SEC filings?
Official SEC filings for Sintx Technologies, Inc. (CIK: 0001269026) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SINT's EPS?
Sintx Technologies, Inc. has a diluted EPS of $-0.70.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SINT's fundamental grade?
Based on our AI fundamental analysis in May 2026, Sintx Technologies, Inc. has a D grade with 96% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SINT stock overvalued or undervalued?
Valuation metrics for SINT: ROE of -312.1% (sector avg: 15%), net margin of -742.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is SINT's AI grade for 2026?
Our dual AI analysis gives Sintx Technologies, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SINT's free cash flow?
Sintx Technologies, Inc.'s operating cash flow is $-2.5M, with capital expenditures of $7.0K. FCF margin is -657.4%.
How does SINT compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -742.4% (avg: 12%), ROE -312.1% (avg: 15%), current ratio 1.04 (avg: 2).